UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Hypersensitivity reactions to teniposide (VM-26): an analysis

Journal of clinical oncology, 1986-08, Vol.4 (8), p.1262-1269

1986

Link zum Volltext

Verfügbarkeit prüfen

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer

Journal of clinical oncology, 1988-05, Vol.6 (5), p.906-918

1988

Link zum Volltext

Verfügbarkeit prüfen

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

JNCI : Journal of the National Cancer Institute, 1989-08, Vol.81 (15), p.1133-1143

1989

Link zum Volltext

Verfügbarkeit prüfen

Acivicin: a new glutamine antagonist in clinical trials

Journal of clinical oncology, 1984-09, Vol.2 (9), p.1064-1071

1984

Link zum Volltext

Verfügbarkeit prüfen

Etoposide (VP-16–213): Current Status of an Active Anticancer Drug

The New England journal of medicine, 1985-03, Vol.312 (11), p.692-700

1985

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system toxicity of fludarabine phosphate

Cancer treatment reports, 1986-10, Vol.70 (10), p.1225

1986

Link zum Volltext

Verfügbarkeit prüfen

Homoharringtonine--perspectives on an active new natural product

Journal of clinical oncology, 1986-10, Vol.4 (10), p.1563-1568

1986

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine: 10 years later

Cancer treatment reports, 1987-07, Vol.71 (7-8), p.737

1987

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II)

Cancer research (Chicago, Ill.), 1982-11, Vol.42 (11), p.4831

1982

Link zum Volltext

Verfügbarkeit prüfen

Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review

Cancer research (Chicago, Ill.), 1988-08, Vol.48 (16), p.4441-4454

1988

Link zum Volltext

Verfügbarkeit prüfen

Dichloromethotrexate--a critical reassessment

Journal of clinical oncology, 1985-08, Vol.3 (8), p.1148-1153

1985

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic response in phase I trials of antineoplastic agents

Cancer treatment reports, 1986-09, Vol.70 (9), p.1105

1986

Link zum Volltext

Verfügbarkeit prüfen

Role of thymidine in biochemical modulation: a review

Cancer research (Chicago, Ill.), 1987-08, Vol.47 (15), p.3911-3919

1987

Link zum Volltext

Verfügbarkeit prüfen

Gallium nitrate: the second metal with clinical activity

Cancer treatment reports, 1986-11, Vol.70 (11), p.1311

1986

Link zum Volltext

Verfügbarkeit prüfen

Clinical drug development: an analysis of phase II trials, 1970-1985

Cancer treatment reports, 1987-01, Vol.71 (1), p.71

1987

Link zum Volltext

Verfügbarkeit prüfen

Biochemical modulation: application of laboratory models to the clinic

Cancer treatment reports, 1986-01, Vol.70 (1), p.219

1986

Link zum Volltext

Verfügbarkeit prüfen

2'Fluoro-5-iodo-arabinosyl-cytosine: a new agent for herpes infections in the immunosuppressed patient

Drug intelligence & clinical pharmacy, 1984-11, Vol.18 (11), p.885

1984

Link zum Volltext

Verfügbarkeit prüfen

Results of NCI-sponsored phase I trials with carboplatin

Cancer treatment reviews, 1985-09, Vol.12, p.43-49

1985

Link zum Volltext

Verfügbarkeit prüfen

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

Cancer research (Chicago, Ill.), 1985-03, Vol.45 (3), p.1408-1412

1985

Link zum Volltext

Verfügbarkeit prüfen

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Investigational new drugs, 1986-01, Vol.4 (3), p.279-284

1986

Link zum Volltext

Verfügbarkeit prüfen

Hexamethylmelamine: A critical review of an active drug

Cancer treatment reviews, 1986-12, Vol.13 (4), p.197-217

1986

Link zum Volltext

Verfügbarkeit prüfen

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

Cancer research (Chicago, Ill.), 1983-12, Vol.43 (12), p.6096-6101

1983

Link zum Volltext

Verfügbarkeit prüfen

The phase II trial

Cancer treatment reports, 1985-11, Vol.69 (11), p.1235

1985

Link zum Volltext

Verfügbarkeit prüfen

Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?

Cancer treatment reports, 1986-08, Vol.70 (8), p.1003

1986

Link zum Volltext

Verfügbarkeit prüfen

A strategy for the development of two clinically active cisplatin analogs : CBDCA and CHIP

Cancer chemotherapy and pharmacology, 1990, Vol.25 (6), p.395-404

1990

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaDrug Evaluation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(41)
Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Oncology
(33)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Pharmacology. Drug Treatments
(26)
Animals
(22)
Antineoplastic Agents
(22)
Neoplasms - Drug Therapy
(15)
Kinetics
(14)
Antineoplastic Agents - Therapeutic Use
(13)
General Aspects
(13)
Drug Evaluation, Preclinical
(11)
Male
(11)
Clinical Trials As Topic
(10)
Female
(10)
Mice
(10)
Adult
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypersensitivity reactions to teniposide (VM-26): an analysis

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

Acivicin: a new glutamine antagonist in clinical trials

Etoposide (VP-16–213): Current Status of an Active Anticancer Drug

Central nervous system toxicity of fludarabine phosphate

Homoharringtonine--perspectives on an active new natural product

Azacitidine: 10 years later

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II)

Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review

Dichloromethotrexate--a critical reassessment

Therapeutic response in phase I trials of antineoplastic agents

Role of thymidine in biochemical modulation: a review

Gallium nitrate: the second metal with clinical activity

Clinical drug development: an analysis of phase II trials, 1970-1985

Biochemical modulation: application of laboratory models to the clinic

2'Fluoro-5-iodo-arabinosyl-cytosine: a new agent for herpes infections in the immunosuppressed patient

Results of NCI-sponsored phase I trials with carboplatin

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent

Hexamethylmelamine: A critical review of an active drug

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

The phase II trial

Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?

A strategy for the development of two clinically active cisplatin analogs : CBDCA and CHIP

Aktive Filter

Suchergebnisse filtern